Delivery Order SPE2DB20D3101-SPE2DB23FRWL8

Award Date 9/1/23
Potential Completion Date 9/5/23
Potential Value $377
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $315,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for sucralfate oral suspension. Under this order, Amerisourcebergen will supply 420,000 milliliters of sucralfate 1 gram per 10 milliliter oral suspension to support the Department of Defense's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in August 2023. No subcontractors or set aside designations...
The Defense Logistics Agency awarded a $2,290.54 firm fixed price delivery order to Amerisourcebergen Drug Corporation for sucralfate oral suspension. The contract calls for the delivery of 420 milliliters of sucralfate 1 gram per 10 milliliters oral suspension to a facility in Conshohocken, Pennsylvania. Performance is required between September 28 and 29, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform as the prime...
The Defense Logistics Agency awarded a $417.86 delivery order contract to Amerisourcebergen Drug Corporation to supply sucralfate oral suspension. As the prime contractor, Amerisourcebergen will deliver 414 milliliters of sucralfate 1 gram per 10 milliliter oral suspension to a facility in Conshohocken, Pennsylvania. The firm fixed price order is being funded by the Defense Logistics Agency and has a period of performance from September 1 through September 5, 2023. Amerisourcebergen...
Defense Logistics Agency awarded an $846 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for sucralfate 1 gm/10 ml susp 420ml. The order was issued on October 17, 2023 with an anticipated completion date of October 18, 2023. Performance will take place in Conshohocken, Pennsylvania. No set-aside designation was applied to this solicitation for sucralfate suspension to support the Defense Logistics Agency's medical supply needs.
The Defense Logistics Agency awarded a $1,649 delivery order to Amerisourcebergen Drug Corporation for 4561327712 sucralfate 1 gm/10 ml susp 420ml. The firm fixed price order is being fulfilled from Amerisourcebergen's Conshohocken, Pennsylvania location to support DLA requirements. No additional details were provided regarding the original solicitation or overarching contract vehicle. Amerisourcebergen will deliver the pharmaceutical product to the Defense Logistics Agency by the scheduled...
The Defense Logistics Agency awarded a $460 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561903666 sucralfate 1 gm/10 ml susp 420ml. As the prime contractor, Amerisourcebergen Drug will deliver the pharmaceutical product to a facility in Conshohocken, Pennsylvania under a one day period of performance from August 22nd to August 23rd, 2023. The Defense Logistics Agency functions to support military readiness by procuring and providing logistics support for critical...
The Defense Logistics Agency awarded a $682 delivery order to Amerisourcebergen Drug Corporation for 4562181252 SUCRALFATE 1 GM/10 ML SUSP 420ML. The firm fixed price order is being fulfilled under the Prime Vendor Pharmaceuticals contract vehicle and will provide the Defense Logistics Agency with sucralfate oral suspension to support the agency's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day, from September 14...
The Defense Logistics Agency awarded a $147,270 delivery order to Amerisourcebergen Drug Corporation for 4562194677 sucralfate 1 gm/10 ml susp 420ml. The firm fixed price order is being fulfilled under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, spanning from September 15 to 18, 2023. No subcontractors or set...
The Defense Logistics Agency awarded a $3,779.76 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561490098, sucralfate 1 gm/10 ml susp 420ml. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 13, 2023 through July 14, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency routinely issues orders against its prime vendor contracts to...
The Defense Logistics Agency awarded a $980 delivery order to Amerisourcebergen Drug Corporation for 4561486649 SUCRALFATE 1 GM/10 ML SUSP 420ML. This firm fixed price order is being fulfilled under an existing DLA contract vehicle and provides sucralfate oral suspension to support DOD health programs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from July 13 to July 14, 2023. No subcontractors or set aside designations were...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRWL8
    Delivery Order

The Defense Logistics Agency awarded a $377,290 firm fixed price delivery order to Amerisourcebergen Drug Corporation for sucralfate oral suspension. Under this contract, Amerisourcebergen will supply 420ml bottles of sucralfate 1 gm/10 ml oral suspension to support the Defense Logistics Agency's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a four day period concluding on September 5, 2023. No subcontractors or set aside designations were identified. This delivery order was issued against an existing DLA pharmaceutical supply vehicle to fulfill requirements for this gastrointestinal drug.

Generated 12/23/23, 7:01 AM